These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3343515)

  • 21. Cryopreservation of newly formed hybridomas.
    De Leij L; Poppema S; The TH
    J Immunol Methods; 1983 Aug; 62(1):69-72. PubMed ID: 6875266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Karyotype analysis of hybridomas producing monoclonal antibodies against different antigens.
    Kontsek P; Novák M; Kontseková E
    Folia Biol (Praha); 1988; 34(2):99-104. PubMed ID: 3396730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Searching for MHC-restricted anti-viral antibodies: antibodies recognizing the nucleoprotein of influenza virus dominate the serological response of C57BL/6 mice to syngeneic influenza-infected cells.
    Tamminen WL; Wraith D; Barber BH
    Eur J Immunol; 1987 Jul; 17(7):999-1006. PubMed ID: 3497045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved fusion technique. II. Stability and purity of hybrid clones.
    Westerwoudt RJ; Naipal AM; Harrisson CM
    J Immunol Methods; 1984 Mar; 68(1-2):89-101. PubMed ID: 6538588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Monoclonal antibodies to the influenza A virus matrix protein that react with viral strains of different subtypes].
    Popov IA; Chervonskiĭ AV; Krivoshein IuS; Krivorutchenko IuL; Bakova AA; Fedorkina OA
    Vopr Virusol; 1992; 37(3):141-4. PubMed ID: 1441439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of limiting dilution in cloning mouse myeloma-spleen hybridomas by human low density lipoproteins.
    Mao SJ; France DS
    J Immunol Methods; 1984 Dec; 75(2):309-16. PubMed ID: 6520402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. I. Significant variation in repertoire expression between individual mice.
    Staudt LM; Gerhard W
    J Exp Med; 1983 Feb; 157(2):687-704. PubMed ID: 6600489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hybridoma cell lines secreting monoclonal antibodies against foot-and-mouth disease virus (FMDV). II. Cloning conditions.
    McCullough KC; Butcher RN; Parkinson D
    J Biol Stand; 1983 Jul; 11(3):183-94. PubMed ID: 6309849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hybridoma antibodies to poliovirus N and H antigen.
    Brioen P; Sijens RJ; Vrijsen R; Rombaut B; Thomas AA; Jackers A; Boeyé A
    Arch Virol; 1982; 74(4):325-30. PubMed ID: 6187316
    [No Abstract]   [Full Text] [Related]  

  • 30. High efficiency creation of human monoclonal antibody-producing hybridomas.
    Dessain SK; Adekar SP; Stevens JB; Carpenter KA; Skorski ML; Barnoski BL; Goldsby RA; Weinberg RA
    J Immunol Methods; 2004 Aug; 291(1-2):109-22. PubMed ID: 15345310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
    Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO
    Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of subtype-specific and cross-reactive helper-T-cell clones recognizing influenza virus hemagglutinin.
    Brown LE; Katz JM; Ffrench RA; Anders EM; White DO
    Cell Immunol; 1987 Oct; 109(1):12-24. PubMed ID: 2958139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hybridoma antibodies to human von Willebrand factor. I. Characterization of seven clones.
    Meyer D; Zimmerman TS; Obert B; Edgington TS
    Br J Haematol; 1984 Aug; 57(4):597-608. PubMed ID: 6204680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of monoclonality of cell lines from sequential dilution assays. Part II.
    Koziol JA
    J Immunol Methods; 1988 Feb; 107(1):151-2. PubMed ID: 3343516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant production and characterization of human anti-influenza virus monoclonal antibodies identified from hybridomas fused with human lymphocytes.
    Misaki R; Fukura N; Kajiura H; Yasugi M; Kubota-Koketsu R; Sasaki T; Momota M; Ono K; Ohashi T; Ikuta K; Fujiyama K
    Biologicals; 2016 Sep; 44(5):394-402. PubMed ID: 27464991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production of monoclonal antibodies against equine influenza A/Equi-2 (H3N8) Indian isolate.
    Singh BK; Sinclair R; Gupta AK; Uppal PK; Yadav MP; Mumford JA
    Indian J Exp Biol; 1993 Sep; 31(9):774-5. PubMed ID: 8276447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preparation and characterization of monoclonal antibodies against the hemagglutinin of H9 subtype of avian influenza virus].
    Zeng YB; Jiao XA; Pan ZM; Huang JL; Zhang PH; Zhang SH; Sun QY; Liu XF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):702-4. PubMed ID: 15555440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of hybridoma cells producing monoclonal antibody against human epsilon (epsilon) chain.
    Majidi J; Hassan ZM
    Hum Antibodies; 2003; 12(3):93-8. PubMed ID: 14646037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for a cloned hybridoma (HO-13-4-9) producing 2 kinds of antibody molecules different in specificity, one directed to Thy 1.2 gene products and the other to antigen on a subpopulation of Thy 1.1 thymocytes.
    Kubota E; Ishikawa H; Saito K
    J Immunol; 1981 Oct; 127(4):1498-503. PubMed ID: 6974196
    [No Abstract]   [Full Text] [Related]  

  • 40. Isolation and characterization of IgG2a-reactive autoantibodies from influenza virus-infected BALB/c mice.
    Fazekas G; Rajnavölgyi E; Kurucz I; Sintár E; Kiss K; László G; Gergely J
    Eur J Immunol; 1990 Dec; 20(12):2719-29. PubMed ID: 2269331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.